Virginia 2020 Regular Session Status: In Committee

HB 876 — Prescription drugs; price transparency.

Last action — Continued to 2021 with substitute in Health, Welfare and Institutions

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House of Delegates
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2020 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Prescription drug price transparency. Requiresevery health carrier, pharmacy benefits manager, wholesale drug distributer, and drug manufacturer to report information about prescription drugprices and related information to the Department of Health and requiresthe Department to make such information available on its website.

Bill Text

  • Impact statement from DPB (HB876) View text Current html January 07, 2020

Action History

  1. Continued to 2021 with substitute in Health, Welfare and Institutions

  2. Subcommittee recommends continuing to 2021

  3. House committee, floor amendments and substitutes offered

  4. Impact statement from DPB (HB876)

  5. Assigned HWI sub: Health Professions

  6. Referred to Committee on Health, Welfare and Institutions

  7. Prefiled and ordered printed; offered 01/08/20 20104912D

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 2 co-sponsors · 145 not signed on

Sponsors (1)

Co-sponsors (2)

Not signed on (145)

145 members have not signed on to this bill.

Show all 145 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 876 do?
Prescription drug price transparency. Requiresevery health carrier, pharmacy benefits manager, wholesale drug distributer, and drug manufacturer to report information about prescription drugprices and related information to the Department of Health and requiresthe Department to make such information available on its website.
Who sponsors HB 876?
HB 876 is sponsored by Shelly A. Simonds, Hurst, Chris L., and Subramanyam, Suhas.
What is the current status of HB 876?
This bill died with 2020 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 876?
Track HB 876 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 876

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 876

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →